NEWS—Frailty care in England deemed deficient bit.ly/4qFV16O #Medsky #Rheumsky

NEW podcast episode🎧 Acting Deputy Editor, Aisling O'Brien, talks to Fiona Pearce & Rachel Tattersall about #HLH mortality rates in Europe Listen now Apple: bit.ly/3Off8LR Spotify: bit.ly/3OFqGYM Full Article: bit.ly/4p5f9hT #Medsky #Rheumsky

🚀 Just launched – our new #goldopenaccess journal on medical imaging and theranostics! Learn more about the journal’s mission and explore related content from The Lancet Group today: hubs.li/Q041CgFF0 #medsky

NEW RESEARCH—Patient profiles and early response in patients with systemic #lupus erythematosus initiating #anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study bit.ly/4aj9YWz Plus, linked Comment bit.ly/3ZliHT6 #Medsky #Rheumsky #SLE

Since their introduction 20 years ago, GLP-1 receptor agonists have revolu­tionised the treatment of diabetes and obesity. In our Feb editorial we discuss the current data on GLP-1 receptor agonists in rheumatic disease bit.ly/4c4N5Zi #Medsky #Rheumsky

NEW REVIEW—The path to interception in psoriatic disease: from conceptual clarity to clinical translation bit.ly/3ZD1NPE #Medsky #Rheumsky

Our Feb 2026 issue is live! Including total versus partial knee replacement, vagus nerve stimulation in hand #OA, mortality due to #HLH, #pregnancy outcomes in #vasculitis, plus much more! thelancet.com/journals/lan... #Medsky #Rheumsky Cover art by @emma-cheng.bsky.social

NEW RESEARCH—Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial bit.ly/4pSERqq Plus, linked Comment bit.ly/49v27Ga #Medsky #Rheumsky

NEW RESEARCH—Transcutaneous auricular vagus nerve stimulation versus sham stimulation in patients with erosive hand osteoarthritis (ESTIVAL): a randomised, multicentre, double-blind, sham-controlled trial bit.ly/4pKm4xD #Medsky #Rheumsky

NEW podcast episode🎧 Deputy Editor, Sophie Woolven, talks to John Isaacs & Josh Bennett about #sarcopenia and the RAMUS study, which looked at the skeletal muscle effects tofacitinib in #RA Apple: bit.ly/49fUy6d Spotify: bit.ly/3YSXxeC Full Article: bit.ly/45tQXPn #Medsky #Rheumsky

"the most disastrous year for US public health policy" The US faces a critical public health crossroads as recent policy shifts threaten decades of progress. What are the implications for future health security and scientific integrity? Our Editorial: spkl.io/63326AcVQy

NEW Viewpoint—Oral glucocorticoid pulse therapy: a modest change in clinical practice with major benefits bit.ly/4apjdGd #Medsky #Rheumsky

NEW RESEARCH—Trends in mortality due to haemophagocytic lymphohistiocytosis across 29 European countries from 2011 to 2021: a retrospective, international, population-based study bit.ly/4p5f9hT #HLH @racheltattersall.bsky.social

EBV and #SLE: causal or concurrence? Read our Jan 2026 editorial bit.ly/49hm6I4 #Medsky #Rheumsky

Our Jan 2026 issue is live! Including #RheumatoidArthritis, #IgG4-related disease, and #SystemicSclerosis, plus much more! thelancet.com/journals/lan... #Medsky #Rheumsky And introducing our cover artist for 2026, Emma Cheng @emma-cheng.bsky.social

NEW REVIEW—Skin cancer in inflammatory arthritis: should we advise screening? bit.ly/3MsvsIc #Medsky #Rheumsky

NEW RESEARCH—Clinical phenotypes, classification, and long-term outcomes of childhood-onset Sjögren's disease into adulthood: a single-centre cohort study bit.ly/4rCIa77 #Medsky #Rheumsky

NEW RESEARCH—Assessing clinical and cost effectiveness of total versus partial knee replacement (TOPKAT): 10-year follow-up of a multicentre, randomised controlled trial bit.ly/4pAMZMq #Medsky #Rheumsky #Orthosky

Our December issue is live! Including #ILD in #RA, #Sjögrens disease, and #SystemicSclerosis, plus much more! thelancet.com/journals/lan... Cover by Sara Gironi Carnevale #Medsky #Rheumsky

NEW—Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis bit.ly/47WEe8q @panlar.bsky.social @lancetrh-americ.bsky.social Free to read with registration on lancet.com

NEW COMMENT—Revisiting safety and refining benefit of rituximab–belimumab combination for refractory #SLE bit.ly/4hWxegq #Medsky #Rheumsky

NEW RESEARCH—IgG4-related disease in the Japanese population: a whole-genome sequencing study bit.ly/4oVaGPm Plus, linked Comment bit.ly/4hOOOmz #Medsky #Rheumsky

Our December issue is out now at www.thelancet.com/journals/lan... Content includes diet in GI disorders; IBS; IBD; oesophageal cancer; alcohol-related liver disease; MASLD + more! #GastroSky #LiverSky #MedSky

👉 Register now: hubs.li/Q03NdTNP0 📆 Nov 20, 2025 | 2pm GMT / 9am EST / 10pm CST Join our expert panel as they explore innate immunity’s role in neurological diseases, and therapies to prevent inflammation-driven neurodegeneration. #neurology #brainhealth #lancetwebinar

NEW in @thelancet.com—Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial bit.ly/47CKHoN Plus, linked Comment bit.ly/4oJVcgV #Medsky #Rheumsky

🔥Hot off the press for #ACR25 🔥 Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study bit.ly/3J5WHHm Plus, linked Comment bit.ly/4300NHF #Medsky #Rheumsky

NEW RESEARCH—Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA bit.ly/3L1F0t5 @jeffsparks.bsky.social

Severe #glucocorticoid-induced #osteoporosis requires a long-term sequential treatment approach consisting of a bone anabolic agent followed by an antiresorptive drug www.thelancet.com/journals/lan... #OpenAccess #MedSky #EndoSky #RheumSky

Attending #ACR25? Sophie Woolven, Deputy Editor, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0 #Medsky #Rheumsky

NEW—The Nobel celebrates tolerance News story by Heather Van Epps bit.ly/47FqW0Y #Medsky #Rheumsky @nobelprize.bsky.social

NEW Profile—Sharon Dowell: specialised treatment for the many bit.ly/4owCwkL #Medsky #Rheumsky

Our November issue is live! Including research on hip #osteoarthritis, #JIA, #BackPain, and #PsoriaticArthritis, plus much more! thelancet.com/journals/lan... Cover by Sara Gironi Carnevale #Medsky #Rheumsky

Attending #ACR25? Sophie Woolven, Deputy Editor, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0

Want to stay up to date with the latest original research, perspectives and insights in your field? 🏥 Explore our Specialty Collections to stay informed with the most current and relevant content published across The Lancet Group. 🔗 thelancet.com/collections

ICYMI

NEW REVIEW—Synovial immunopathology in psoriatic arthritis: cellular and molecular insights bit.ly/4pKi9Su #Medsky #Rheumsky

NEW RESEARCH—Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study bit.ly/3W2mXVX #Medsky #Rheumsky

NEW podcast episode🎧 Deputy Editor, Sophie Woolven, talks to @ScottUhlrich about personalised gait retraining for knee #osteoarthritis Apple: bit.ly/3VBBXcZ Spotify: bit.ly/47W9TbI Full Article: bit.ly/4nk2rfd #Medsky #Rheumsky #Biomechsky

Join Zoë Mullan and other Lancet Group editors to learn more about the SAGER guidelines for sex- and gender-based analyses, explore real research examples, and gain practical tips for responding to the guidelines. 📅 21 October, 2pm BST 👉 Register: hubs.li/Q03FQ_6l0

Our October issue is live! Including research on #vaccination in #rheumatoidarthritis and #hydroxychloroquine during #pregnancy, two Reviews on #VEXAS, plus much more! thelancet.com/journals/lan... Cover by Sara Gironi Carnevale #Medsky #Rheumsky

NEW RESEARCH—The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021 bit.ly/4mhrbDx #Medsky #Rheumsky #GBDStudy @ihmeuw.bsky.social

NEW—Unscientific vaccine policy endangers vulnerable patients Read our latest editorial bit.ly/3HWybYD #Medsky #Rheumsky

Our inaugural issue is out now! 🎉 Explore and download our first issue and read featured content, Editor's picks, announcements, and much more on our journal homepage: hubs.li/Q03GFPRK0 Thank you to our authors and reviewers! #medsky #physician-researcher #obgynsky #womenshealthsky

NEW RESEARCH—Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data bit.ly/4mc76P1 #Medsky #Rheumsky

NEW COMMENT—Targeting B-cell activation to tackle both patient-reported and systemic disease outcomes in Sjögren's disease bit.ly/46xopoY #Medsky #Rheumsky

NEW RESEARCH—Serum biomarkers associated with baricitinib response in patients with juvenile idiopathic arthritis: a post-hoc analysis of the phase 3 JUVE-BASIS trial bit.ly/4nrPIqK #JIA #Medsky #Rheumsky

NEW—Two Reviews on VEXAS syndrome, a disorder caused by an acquired monogenic somatic UBA1 gene mutation which affects ubiquitination and triggers immune dysregulation, leading to diverse clinical and pathological features resembling inflammatory rheumatic diseases #Medsky #Rheumsky #Heamsky

NEW RESEARCH—Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids vs methotrexate and corticosteroids in early, untreated #psoriaticarthritis bit.ly/465KoSC @drailyntan.bsky.social @universityofleeds.bsky.social @nihrleedsbrc.bsky.social #Rheumsky #Medsky

NEW Correspondence—Further progression in patients with systemic sclerosis-associated interstitial lung disease Letter ➡️https://bit.ly/45KZm1v Authors' reply ➡️https://bit.ly/3JKrfhy Linked to this Article ➡️https://bit.ly/4gbwFi0 #Medsky #Rheumsky

📢Calling all aspiring rheumatologists in Sub-Saharan Africa! #EULAR and #AFLAR are enhancing #rheumatology training in Sub-Saharan Africa with free access to high quality online courses. Register here: https://pulse.ly/7n75afapml 📅Deadline: 15 September 2025. #MedicalEducation